Search Results 401-410 of 17891 for Coagulation
Active disseminated intravascular coagulation (DIC); Active central nervous system (CNS) leukemia; Active, uncontrolled infection; patients with infection ...
... coagulation studies, or total bilirubin concentration (in mg/dL) > 8 x weight (in kg)); chromosomal anomalies; congenital or acquired gastrointestinal ...
Teriparatide injection is used to treat osteoporosis in postmenopausal women who are at high risk for bone fracture. It reduces the risk of having bone and ...
... coagulation studies (INR/PTT) and platelet counts suitable for surgery per surgeon discretion. Exclusion Criteria: -Second primary malignancy -History of ...
Unable to discontinue use of anti-coagulant/antiplatelet therapy as per local standard. ... Abnormal coagulation profile (Platelets < 80,000), PT (> 14) or PTT (> ...
... coagulation profile prior to first dose of protocol therapy * Note: Patients on full-dose anticoagulation must be on a stable dose (minimum duration 14 days) ...
Any endoscopic treatment to current target pathology [Endoscopic intervention examples: Photodynamic therapy, Halo, Cryotherapy, Multi-polar coagulation] ...
Have adequate coagulation function. Have adequate hepatic function. The participant does not have: cirrhosis at a level of Child-Pugh B (or worse); cirrhosis ...
Adequate coagulation laboratory assessments, as follows: Prothrombin time (PT) or activated partial thromboplastin time (APTT) < 1.5 x upper limit of normal ...
Any chronic condition for which anti-coagulation cannot be safely interrupted for liver biopsy; Positive pregnancy test; Peripheral blood Tregs <30/μL at ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.